GLP-1 receptor agonist medications include: Wegovy* and Ozempic* (Semaglutide) Zepound* and Mounjaro* (Tirzepatide) Saxenda* and Victoza* (Liraglutide) *Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda and Victoza are registered trademarks of their respective owners
Prioritize Activity: Gentle movements, like walking, yoga, or stretching, can help improve digestion and minimize gastrointestinal discomfort
When Congress created the program, it explicitly excluded coverage for drugs associated with weight loss or gain
The companys Series B funding came from Viking Global Investors, Sofinnova Investments, ARCH Venture Partners, Fidelity, and others
Our commitment to you We are here to support you through your weight loss journey with personalized guidance, regular check-ins and a focus on long-term success
GLP-1 users prioritize protein per bite and favor high fiber, while shunning sugar and seeking small serving sizes, healthy snacks, and new beverages